MDB Capital Holdings LLC

MDB Capital Holdings LLC (MDBH) Stock Analysis

$2.953

+0.054 (+1.82%)At close

Loading chart…
High
2.960
Open
2.860
VWAP
2.92
Vol
2.24K
Mkt Cap
67.39M
Low
2.860
Amount
6.56K
EV/EBITDA, TTM
0.00

MDB Capital Holdings, LLC is a holding company that has three subsidiaries: MDB CG Management Company (MDB Management), Public Ventures, LLC (Public Ventures), and PatentVest, Inc. (PatentVest), and has a partner company, MDB Minnesota One, Inc. Its segments include broker dealer & intellectual property service, and technology development. The broker dealer & intellectual property service segment has two subsidiaries, Public Ventures and PatentVest. Public Ventures is a full-service broker dealer firm focusing on conducting private and public securities offerings. PatentVest offers in-depth patent research used for investment banking due diligence. The technology development segment includes MDB Minnesota One, Inc., a research and development stage company that is developing a small molecule senescence platform. MDB Management is an administrative entity whose purpose is to conduct, and wherever possible, to consolidate shared services/resources, for its United States-based operations.

www.mdb.com

AI analysis of MDB Capital Holdings LLC (MDBH)

hold

MDB Capital Holdings LLC is not a strong buy at this moment due to its current price of 2.95, which is down 15.63% year-to-date, and a low RSI of 42.64 indicating potential weakness. The company has shown some positive developments in leadership and cash management, but the net income remains negative with a recent EPS of -0.89, highlighting ongoing financial struggles. The main risk is the negative net margin of -15309.09% in the most recent quarter, which raises concerns about profitability.

Valuation Metrics

The current forward P/E ratio for MDB Capital Holdings LLC (MDBH) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Overvalued
0.00
Undervalued
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Overvalued
0.00
Undervalued
0.00

Alphio AI Price Scenarios for MDBH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%MDBH

$5.48

Scenario price

B

Base

Base · 50%MDBH

$5.20

Scenario price

B

Bear

Bear · 25%MDBH

$5.07

Scenario price

Events Timeline

2025-06-02 (ET)

17:54:11

MDB Capital announces board transitions

2025-05-27 (ET)

16:12:20

ClearSign Board to expand in size to seven directors

2025-05-21 (ET)

09:04:20

MDB Capital provides Q1 update, continued to work on new opportunities

2025-02-21 (ET)

16:07:58

eXoZymes president, chairman Hayat transitions out of roles

News

MDBH FAQ — answered by Alphio AI

MDB Capital Holdings, LLC is a holding company that has three subsidiaries: MDB CG Management Company (MDB Management), Public Ventures, LLC (Public Ventures), and PatentVest, Inc. (PatentVest), and has a partner company, MDB Minnesota One, Inc. Its segments include broker dealer & intellectual property service, and technology development. The broker dealer & intellectual property service segment has two subsidiaries, Public Ventures and PatentVest. Public Ventures is a full-service broker dealer firm focusing on conducting private and public securities offerings. PatentVest offers in-depth patent research used for investment banking due diligence. The technology development segment includes MDB Minnesota One, Inc., a research and development stage company that is developing a small molecule senescence platform. MDB Management is an administrative entity whose purpose is to conduct, and wherever possible, to consolidate shared services/resources, for its United States-based operations. It operates in the Financials sector (FINANCE SERVICES industry).

MDB Capital Holdings LLC is not a strong buy at this moment due to its current price of 2.95, which is down 15.63% year-to-date, and a low RSI of 42.64 indicating potential weakness. The company has shown some positive developments in leadership and cash management, but the net income remains negative with a recent EPS of -0.89, highlighting ongoing financial struggles. The main risk is the negative net margin of -15309.09% in the most recent quarter, which raises concerns about profitability.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started